Integra Lifesciences (IART) 76.68 $IART 29.5% Return

New Post Public Reply Private Reply Replies (0) Message Board

Jun 11, 2016 at 9:02 AM

Integra Lifesciences (IART) 76.68 $IART

29.5% Return Seen to Date on SmarTrend Integra LifeSciences Call (IART)
Comtex SmarTrend(R) - Fri Jun 10, 1:07PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 4 months, Integra LifeSciences has returned 29.50% as of today's recent price of $76.22.
IART: 76.68 (-0.95)

Integra (IART): Strong Revenue Growth on Global Prospects
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:16AM CDT
On May 31, 2016, we issued an updated research report on Plainsboro, NJ-based Integra LifeSciences Holdings Corporation (IART).
IART: 76.68 (-0.95), ANIP: 52.05 (-1.64), NEO: 8.40 (-0.62), RTRX: 17.40 (-0.30)

Integra LifeSciences Has Returned 23.6% Since SmarTrend Recommendation (IART)
Comtex SmarTrend(R) - Thu May 26, 1:24PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 3 months, Integra LifeSciences has returned 23.61% as of today's recent price of $72.75.
IART: 76.68 (-0.95)

Integra LifeSciences to Present at the Jefferies 2016 Healthcare Conference in June 2016
GlobeNewswire - Wed May 25, 3:05PM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in June:
IART: 76.68 (-0.95), IARTV: 65.00 (-37.45)

Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:22AM CDT
Integra LifeSciences Holdings Corporation (IART) recently launched Integra Fin-Lock Glenoid.
IART: 76.68 (-0.95), HSKA: 35.56 (-0.56), ANIP: 52.05 (-1.64), NEO: 8.40 (-0.62)

Integra LifeSciences launches Integra(R) Fin-Lock(TM) Glenoid for the Titan(TM) Modular Shoulder System
GlobeNewswire - Mon May 23, 7:30AM CDT
Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of the Integra(R) Fin-Lock(TM) Glenoid. This addition to the Titan(TM) Modular Shoulder System increases the glenoid offerings to include features intended to help maximize long-term fixation and implant longevity.
IART: 76.68 (-0.95), IARTV: 65.00 (-37.45)

Shares of IART Up 22.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 19, 1:05AM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 3 months, Integra LifeSciences has returned 22.10% as of today's recent price of $71.86.
IART: 76.68 (-0.95)

Uptrend Call Working As Integra LifeSciences Stock Rises 24.3% (IART)
Comtex SmarTrend(R) - Wed May 11, 1:17PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 3 months, Integra LifeSciences has returned 24.27% as of today's recent price of $73.14.
IART: 76.68 (-0.95)

Integra LifeSciences Receives FDA Approval for Integra(R) Omnigraft(TM) Dermal Regeneration Matrix, Clearing the Way for Commercial Release
GlobeNewswire - Wed May 11, 7:30AM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company has received approval from the U.S. Food and Drug Administration (FDA) for the packaging of its new product, Integra(R) Omnigraft(TM) Dermal Regeneration Matrix, which clears the way for its commercial release. The product's unique packaging is designed for ease of handling and application in the outpatient wound care setting.
IART: 76.68 (-0.95), IARTV: 65.00 (-37.45)

Integra LifeSciences to Present at the Bank of America Merrill Lynch 2016 Health Care Conference and the UBS Global Healthcare Conference in May 2016
GlobeNewswire - Tue May 03, 3:15PM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in May:
IART: 76.68 (-0.95), IARTV: 65.00 (-37.45)

Integra (IART) Beats on Q1 Earnings, Grows Organically
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 12:36PM CDT
Integra LifeSciences Holdings Corporation (IART) reported adjusted earnings per share (EPS) of 74 cents in the first quarter of 2016.
IART: 76.68 (-0.95), ANIP: 52.05 (-1.64), ANIK: 49.16 (+0.24), ALQA: 1.11 (-0.03)

Integra LifeSciences Reports First Quarter 2016 Financial Results
GlobeNewswire - Wed Apr 27, 5:01AM CDT
Revenue of $236.8 million; Organic Revenue Increased 8.9%;
IART: 76.68 (-0.95)

Integra LifeSciences Provides Update for Omnigraft(TM) Commercialization Plans, Including Expectations for an Earlier Launch
GlobeNewswire - Wed Apr 27, 5:00AM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company is prepared to launch Omnigraft(TM) Dermal Regeneration Matrix in June 2016, pending receipt of final U.S. Food and Drug Administration (FDA) packaging approval.
IART: 76.68 (-0.95), IARTV: 65.00 (-37.45)

Integra LifeSciences Announces Agreement with AlloSource(R) to Commercialize HuMend(TM), Human Acellular Dermal Matrix
GlobeNewswire - Tue Apr 26, 3:15PM CDT
Integra LifeSciences Holding Corporation (NASDAQ:IART), a leading global medical technology company, today announced its entry into an agreement with AlloSource, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing.
IART: 76.68 (-0.95)

Integra LifeSciences Announces Initial Clinical Use of the Cadence(TM) Total Ankle System in the United States
GlobeNewswire - Tue Apr 26, 3:15PM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the first ten procedures using the Integra(R) Cadence Total Ankle System were successfully completed by Dr. Selene Parekh and Dr. David Pedowitz.
IART: 76.68 (-0.95), IARTV: 65.00 (-37.45)

Integra LifeSciences Announces Agreement with Vomaris Wound Care, Inc. to Commercialize VolTAC(TM) Antimicrobial Wound Dressing
GlobeNewswire - Thu Apr 14, 7:30AM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that its subsidiary, Integra LifeSciences Corporation, has entered into an agreement with Vomaris Wound Care, Inc., a company specializing in microcurrent solutions for the advanced wound care market. Vomaris's Advanced Microcurrent Technology(R) (AMT) platform recently earned Frost & Sullivan's 2016 Best Practices Award for New Product Innovation for pioneering technology that utilizes electrical energy for wound management.
IART: 76.68 (-0.95), IARTV: 65.00 (-37.45)

Integra LifeSciences to Host Its First Quarter 2016 Earnings Results Conference Call on April 27, 2016
GlobeNewswire - Wed Apr 06, 3:00PM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its first quarter 2016 financial results on Wednesday, April 27, 2016. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.
IART: 76.68 (-0.95), IARTV: 65.00 (-37.45)

Integra LifeSciences Awarded $10.3 Million Department of Defense Contract
GlobeNewswire - Thu Mar 10, 7:30AM CST
Integra LifeSciences Holding Corporation (NASDAQ:IART), a leading global medical technology company, today announced that through its partnership with Buffalo Supply, it has received a five-year, $10.3 million contract with the U.S. Department of Defense (DoD), to provide greater access to both its Specialty Surgical Solutions and Orthopedics & Tissue Technology products. The contract is specified for the Defense Logistics Agency (DLA) Medical Electronic Catalogue (ECAT). The DLA purchases approximately $4.5 billion of medical material each year for DoD facilities around the world, as well as other U.S. federal agencies.
IART: 76.68 (-0.95)

Integra LifeSciences Global Prospects Bright, Risks Remain
Zacks Equity Research - Zacks Investment Research - Fri Mar 04, 1:00PM CST
Integra (IART) ended 2015 on a satisfactory note with its bottom-line figure surpassing our estimate. However foreign exchange
IART: 76.68 (-0.95), VASC: 39.58 (-0.56), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hyperliquid Expands Stock Buyback to $100 Million

Diving Into Hyperliquid's $100 Million Bold Move Let’s cut through the corporate fluff—Hyperliquid Strategies Inc. just cranked up their stock repurchase program to a cool $100 million. Yep, that’s right—the brain trust behind NASDAQ:PURR has pulled out the checkbook to buy more of its own shares. This decision, unveiled on October 23, 2026, is like tossing a...

Think Together Marks 20 Years of ASES Impact in CA

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Home Insurance Gaps: Risky Assumptions Uncovered

Unseen Threats to Homeownership Safety Liability gaps in insurance are like those stubborn stains on the carpet you keep missing—nearly invisible until you're flat on your face. In Alpharetta and Fulton County, homes aren't as secure from financial pitfalls as their charming façades suggest. So, what's the danger that folks are glossing over here? Hidden Dangers of...

Gemmy's Orchestra of Lights Op. 2 Unveils New Show

Jazzing Up the Holidays with Gemmy's Latest Innovation Just when you thought holiday displays couldn't get more extravagant, along comes Gemmy with its latest wonder—the Orchestra of Lights™ Op. 2. Exclusively hitting Lowe's shelves, this isn't your average set of twinkling bulbs. It's an all-out sensory assault, mixing tunes straight out of yuletide hit lists with...

Chemours Faces Class Action Over Fraud Allegations

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Northern Virginia's Housing Inventory Surges Despite Market Pressures

Unexpected Surge in Northern Virginia's Inventory Walking around Fairfax these days, you might feel like you're in a time warp, especially if you're tracking the housing market. See, while the rest of the country's housing market groans under sluggish sales and creeping prices, Northern Virginia's doing a dance of its own. Inventory's ballooning faster than a parade...

Civista Welcomes Healthcare Leader to Boost Growth

Expanding the Boardroom with Healthcare Expertise In an unexpected twist for Civista Bancshares (NASDAQ: CIVB), the financial holding company is roping in some healthcare brass to its board. Jeremy Normington-Slay just snagged a seat at Civista's table, and he's bringing his tough-sledding healthcare leadership chops straight from Firelands Health. A $4.3 billion outfit...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Understanding New Jersey's Gun Laws Through Legal Eyes

Cracking New Jersey's Complex Legal Code You ever try to decode the rulebook judges play by when gun possession and aggravated assault enter the picture in New Jersey? Well, it's as tricky as picking a safe with a wet noodle. Thankfully, a legal eagle named Ed Weinstock sheds some light on this murky terrain. Now, this isn't just some academic exercise—it's a look into...

mF International Shuts Down Legacy Business to Focus on BCH

mF International's Bold Digital Leap It’s a big move in the financial landscape when a firm decides to shake things up and pivot hard towards the digital frontier. mF International Limited (NASDAQ:MFI) is shutting the door on its legacy financial trading solutions and dedicating itself entirely to the budding world of digital assets. This isn’t just another facelift;...